Sally Lyons Wyatt, global executive vice president and chief advisor for consumer goods and foodservice insights at Circana, tells this week’s Video Forum about the state of American consumers in an inflationary environment. She also discusses changing shopping patterns, the robust performance of store brands, and how retailers and CPG companies are trying to drive sales.
Video Forum: Sally Lyons Wyatt, Circana, Part 1
Sally Lyons Wyatt, global executive vice president and chief advisor for consumer goods and foodservice insights at Circana, tells this week’s Video Forum about the state of American consumers in an inflationary environment.
Related
Kroger-Albertsons merger goes on trial in an Oregon federal court
The FTC faces off against lawyers from Albertsons and Kroger in a fight over competition in the grocery channel.
FDA approves Moderna’s updated COVID-19 vaccine
Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older.
Kroger sues FTC, claims merger challenge violates Constitution
The company argues that by proceeding in its administrative tribunal, in addition to the separate action in federal court, the FTC is violating Constitutional protections.
CRN to Federal Appeals Court: NY AG’s arguments don’t support denial of preliminary injunction in NY age restrictions case
CRN’s most recent brief argues that the NY AG does not meaningfully address CRN’s arguments about the Act’s constitutional infirmities.
Latest
Crave Retail to showcase smart fitting room and store engagement platform at NRF 2026
Crave Retail will showcase its AI-powered smart fitting room and in-store engagement platform powered by Zebra’s retail displays, mobile devices, and RFID solutions.
Ro launches Wegovy pill through deal with Novo Nordisk
Ro first integrated directly with Novo Nordisk in April 2025 and has been a key part of the manufacturer's direct-to-patient expansion to date.
Albertsons Media Collective launches incrementality measurement
Aims to prove true media impact of in-store campaigns and plans expansion.
Camber Pharmaceuticals reviews 2025 achievements and plans 2026 growth
Camber’s year featured broad generic launches, specialty and oncology introductions, emphasizing access, affordability, and supply reliability in the U.S.